Invenomic Capital Management’s HyreCar Inc. Common Stock HYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-502,881
Closed -$463K 178
2022
Q3
$463K Sell
502,881
-460,655
-48% -$430K 0.04% 145
2022
Q2
$588K Buy
963,536
+5,257
+0.5% +$6.74K 0.04% 140
2022
Q1
$1.86M Buy
958,279
+750,534
+361% +$2.32M 0.2% 102
2021
Q4
$979K Buy
207,745
+131,881
+174% +$824K 0.21% 108
2021
Q3
$645K Sell
75,864
-77,395
-50% -$1.06M 0.21% 97
2021
Q2
$3.21M Sell
153,259
-154,129
-50% -$2.37M 0.77% 30
2021
Q1
$3.01M Buy
307,388
+92,714
+43% +$913K 0.67% 32
2020
Q4
$1.53M Sell
214,674
-49,284
-19% -$270K 0.39% 54
2020
Q3
$832K Buy
263,958
+34,367
+15% +$117K 0.46% 71
2020
Q2
$673K Buy
229,591
+24,342
+12% +$50.5K 0.5% 69
2020
Q1
$279K Sell
205,249
-185,882
-48% -$523K 0.23% 105
2019
Q4
$1.03M Buy
+391,131
New +$948K 0.41% 79

Other funds holding HYRE

Invenomic Capital Management's HYRE Position: Q4 2022 in Review

Invenomic Capital Management sold out of HyreCar Inc. Common Stock (HYRE) in Q4 2022, closing a stake of 502,881 shares — an estimated $463K sold.

Invenomic Capital Management first reported a position in HYRE in Q4 2019 and held it in 12 quarters. The position peaked at $3.21M in Q2 2021. 35 funds tracked by Wall St. Rank hold HYRE as of Q4 2022.

  • Invenomic Capital Management reported no remaining HyreCar Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 502,881 HyreCar Inc. Common Stock shares in Q4 2022, an estimated $463K.
  • Invenomic Capital Management first reported a position in HyreCar Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Invenomic Capital Management's HyreCar Inc. Common Stock position peaked at $3.21M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held HyreCar Inc. Common Stock as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.